Regular ArticlePrP Deposition, Microglial Activation, and Neuronal Apoptosis in Murine Scrapie☆
References (35)
- et al.
Precise targeting of the pathology of the sialogycoprotein, PrP, and the vacuolar degeneration in mouse scrapie
Neurosci. Lett.
(1989) - et al.
Agent-strain differences in the distribution and intensity of grey matter vacuolation
J. Comp. Pathol.
(1973) - et al.
Cytotoxicity of prion protein peptide (PrP106–126) differs in mechanism from the cytotoxic activity of the Alzheimer's disease amyloid peptide, Aβ25–35
Neurodegeneration
(1996) - et al.
Murine scrapie-infected neurons release excess prion protein into the extracellular space
Neurosci. Lett.
(1994) - et al.
Correlative light and electron microscopic studies of PrP localisation in 87V scrapie
Brain Res.
(1994) - et al.
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain
Neuroscience
(1990) - et al.
Cytoprotective effect of MNDA receptor antagonists on prion protein (prionSc
Eur. J. Pharmacol.
(1993) - et al.
Flupirtine partially prevents neuronal injury induced by prion protein fragment and lead acetate
Neurodegeneration
(1995) - et al.
Normal host prion protein necessary for scrapie-induced neurotoxicity
Nature
(1996) - et al.
Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment
NeuroReport
(1994)
Role of microglia and host prion protein in neurotoxicity of a prion protein fragment
Nature
(1996)
Changes in the localization of brain prion proteins during scrapie infection
Neurology
(1987)
Neurotoxicity of a prion protein fragment
Nature
(1993)
Retinopathy in mice with experimental scrapie
Neuropathol. Appl. Neurobiol.
(1986)
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
J. Cell Biol.
(1992)
Neuronal death in scrapie-infected mice is due to apoptosis
Brain Pathol.
(1995)
Cited by (190)
Stem cell-based therapeutic strategy in delaying prion disease
2021, Stem Cells and AgingCyclophillin A deficiency accelerates RML-induced prion disease
2019, Neurobiology of DiseaseGanglioside Synthase Knockout Reduces Prion Disease Incubation Time in Mouse Models
2019, American Journal of PathologyCitation Excerpt :A possibility that the alteration in ganglioside composition might affect the activation of glial cells cannot be excluded. Although the role of glial cells in the pathogenesis of prion diseases is controversial, both microglia and astroglia are activated in prion diseases.40–43 The decreased number of microglia and astroglia in the Chandler-inoculated GD2/GM2 KO mice might simply reflect the decreased PrPTSE deposition.
Cell-based therapy against prion diseases
2019, Current Opinion in Pharmacology
- ☆
L. CourtB. Dodet, Eds.
Copyright © 1997 Academic Press. All rights reserved.